1-20 of 47
Mingzhi Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Huangming Hong, Mingzhi Zhang, Zhigang Peng, Jianzhen Shen, Yuerong Shuang, Hui Zhou, Hongqiang Guo, He Huang, Fei Li, Zhengzi Qian, Lihong Liu, Liang Wang, Wei Yang, Liling Zhang, Pengcheng He, Shen Qian, Fugen Li, Meng Li, Tongyu Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 304.
https://doi.org/10.1182/blood-2023-180372
Published: 2023
Journal Articles

Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study

Elzbieta Iskierka-Jazdzewska, Won Seog Kim, Seok-Goo Cho, Tae Min Kim, Isidro Jarque, Tadeusz Robak, Michelle Poon, H. Miles Prince, Sung Yong Oh, Francesca Lim, Cecilia Carpio, Tran-Der Tan, Sabarish Ayyappan, Antonio Gutiérrez, Huilai Zhang, Junning Cao, Mingzhi Zhang, Benoit Tessoulin, Jingjin Li, Cristina Ivanescu, Matthew Reaney, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, James Harnett, Lei Chi, Jan Walewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4504.
https://doi.org/10.1182/blood-2023-180743
Published: 2023
Journal Articles

Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma

Zijun Y. Xu-Monette, Yong Li, Thomas Snyder, Tiantian Yu, Tingxun LU, Alexandar Tzankov, Carlo Visco, Govind Bhagat, Wenbin Qian, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Frederick Hagemeister, Heounjeong Go, Maurilio Ponzoni, Andrés José María Ferreri, Michael Møller, Benjamin M. Parsons, Joannes H.J.M. Van Krieken, Yingjun Wang, Miguel Angel Piris, Jane Winter, Qingyan Au, Ilan Kirsch, Mingzhi Zhang, John D Shaughnessy, Jr, Bing Xu, Ken H. Young
Journal: Blood
Blood (2023) 142 (Supplement 1): 429.
https://doi.org/10.1182/blood-2023-179972
Published: 2023
Journal Articles

Efficacy and Safety of Chemotherapy (DDGP vs VIPD) Followed Radiotherapy Vs Radiotherapy Followed Chemotherapy (DDGP vs VIPD) Vs Radiotherapy Alone for Newly Diagnosed Early Stage Extranodal Natural Killer/T Cell Lymphoma: Final Results of a Prospective, Multicenter, Randomized, Controlled Clinical Trial

Mingzhi Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Yu Chang, Xudong Zhang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Xiyang Liu, Xiaolong Wu, Liqun Zou, Hui Zhou, Hongwei Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 1690.
https://doi.org/10.1182/blood-2023-188245
Published: 2023
Journal Articles

Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Sabarish Ayyappan, Won Seog Kim, Tae Min Kim, Jan Walewski, Seok-Goo Cho, Isidro Jarque, Elzbieta Iskierka-Jazdzewska, Michelle Poon, Sung Yong Oh, Francesca Lorraine Wei Inng Lim, Cecilia Carpio, Tran-Der Tan, Antonio Gutiérrez, Huilai Zhang, Junning Cao, Mingzhi Zhang, Benoit Tessoulin, Jingjin Li, Melanie Ufkin, Saleem Shariff, Lei Chi, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, H. Miles Prince
Journal: Blood
Blood (2023) 142 (Supplement 1): 436.
https://doi.org/10.1182/blood-2023-179818
Published: 2023
Journal Articles

Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration

Zijun Y. Xu-Monette, Li Yu, Cancan Luo, Yong Li, Govind Bhagat, Alexandar Tzankov, Carlo Visco, Xiangshan Fan, Xiaosheng Fang, Karen Dybkaer, Ali Sakhdari, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, F. B. Hagemeister, Dennis O'Malley, Qingyan Au, Harry Nunns, Heounjeong Go, Maurilio Ponzoni, Andrés José María Ferreri, Michael Møller, Benjamin M. Parsons, Joannes H.J.M. Van Krieken, Miguel Piris, Jane Winter, Bing Xu, Mingzhi Zhang, Ken H. Young
Journal: Blood
Blood (2023) 142 (Supplement 1): 6079.
https://doi.org/10.1182/blood-2023-178366
Published: 2023
Journal Articles

Phase I Clinical Study of PA3-17 Injection in Patients with Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

Lijuan Hu, Hui Yu, Heng Mei, Dehui Zou, Yaqing Li, Danying Liao, Wei Liu, Yan Xu, Lei Zhang, Xudong Zhang, Zhenchang Sun, Xinhua Wang, Min Wang, Fengtao You, Huimin Meng, Tian Wang, Bozhen Zhang, Lin Yang, Mingzhi Zhang, Xiaojun Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3471.
https://doi.org/10.1182/blood-2023-178484
Published: 2023
Journal Articles

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Xinfeng Chen, Yu Ping, Ling Li, Lei Zhang, Xudong Zhang, Jianmin Huang, Jia Liu, Gui Li, Huan Shi, Jiaping He, Yi Liang, Lihong Weng, Wenjie Yin, Lianjun Shen, Wei William Cao, Wenling Li, Mingzhi Zhang, Yi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6847.
https://doi.org/10.1182/blood-2023-185476
Published: 2023
Journal Articles

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

Xinxin Cao, Jie Jin, Fu Cheng Cheng, Shuhua Yi, Weili Zhao, Zimin Sun, Wei Yang, Dengju Li, Guohui CUI, Jianda Hu, Ting Liu, Yongping Song, Bing Xu, Zunmin Zhu, Wei Xu, Mingzhi Zhang, Sichen Li, Weige Wang, Renbin Zhao, Daobin Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 3039.
https://doi.org/10.1182/blood-2023-181500
Published: 2023
Journal Articles

Prompt Assessment of Tumor Load and Treatment Response in Patients with Lymphoma By a Blood-Based Multi-Omics Approach

Xinhua Wang, Zhiming Li, Yu Chang, Shiyong Li, Wei Wu, Fangyuan Chang, Yinyin Chang, Dandan Zhu, Mingzhi Zhang, Mao Mao
Journal: Blood
Blood (2022) 140 (Supplement 1): 6415–6416.
https://doi.org/10.1182/blood-2022-165642
Published: 2022
Journal Articles

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Xudong Zhang, Wenhua Wang, Shanshan Ma, Mengke Fan, Linan Zhu, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Mingzhi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12075–12076.
https://doi.org/10.1182/blood-2022-159383
Published: 2022
Journal Articles

Preliminary Safety and Efficacy Evaluation of IMM0306, a CD47 and CD20 Bispecific Monoclonal Antibody-Trap (mAb-Trap), from an Ongoing Phase I Dose-Escalation Study in Patients with Relapsed or Refractory B-Cell Non- Hodgkin's Lymphoma (R/R B-NHL)

Yuankai Shi, Yongping Song, Mingzhi Zhang, Hongmei Jing, Zhen Wang, Zhiming Li, Junyuan Qi, Fei Li, Wenyu Li, Jianliang Yang, Siman Gao, Huizi Ma, Heming He, Qiying Lu, Wenzhi Tian
Journal: Blood
Blood (2022) 140 (Supplement 1): 9323–9324.
https://doi.org/10.1182/blood-2022-157862
Published: 2022
Journal Articles

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Lu Zhang, Yujun Dong, Hongling Peng, Hao Li, Mingzhi Zhang, Hui-Han Wang, Qinhua Liu, Liping Su, Liye Zhong, Wenjun Wu, Liang Huang, Xiaojing Yan, Lei Fan, Wenjiao Tang, Zhenling Li, Lintao Bi, Yan Li, Guangxun Gao, Li Gao, Ting-Bo Liu, Yongqiang Wei, Yao Liu, Yu Li, Hui Zhou, Chunyan Sun, Wenbin Qian, Dehui Zou, Huilai Zhang, Kaiyang Ding, Xiaobo Wang, Ou Bai, Wenrong Huang, Bing Chen, Lin Yang, Jia Song, Da Gao, Tong Chen, Jun Luo, Shuye Wang, Liangming Ma, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 3609–3611.
https://doi.org/10.1182/blood-2022-158675
Published: 2022
Journal Articles

Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patients

Daobin Zhou, Jie Jin, Zheng-zheng Fu, Shuhua Yi, Wei Li Zhao, Zimin Sun, Wei Yang, Dengju Li, Guohui Cui, Jianda Hu, Ting Liu, Yongping Song, Bing Xu, Zunmin Zhu, Wei Xu, Mingzhi Zhang, Yamin Tian, Huaqiang Zhu, Bin Zhang, Renbin Zhao, Xiang-Yang Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 46.
https://doi.org/10.1182/blood-2021-149350
Published: 2021
Journal Articles

Integrating Circulating Tumor DNA Features and Plasma Protein Markers to Detected Early Lymphoid Neoplasm

Xinhua Wang, Yu Chang, Dandan Zhu, Shiyong Li, Shuaipeng Geng, Yinyin Chang, Yan Chen, Mao Mao, Mingzhi Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4489.
https://doi.org/10.1182/blood-2021-145683
Published: 2021
Journal Articles

Analysis of the Tumor Microenvironment By Quantitative Immunohistochemistry Reveals Novel Predictors in Classic Hodgkin Lymphoma Treated with Anti-PD1 Therapy

Hui Yu, Jiali Ni, Zhenchang Sun, Mingzhi Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4530.
https://doi.org/10.1182/blood-2021-152666
Published: 2021
Journal Articles

The Impact of the Immunophenotyping Characteristics of Patients' Peripheral Blood on the Manufacturing and Clinical Outcome of CD7-Targeted Chimeric Antigen Receptor T Cells

Mingzhi Zhang, Xiaorui Fu, Huimin Meng, Min Wang, Yu Wang, Guifang Pan, Lei Zhang, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Xiaolong Wu, Yanmei Zhao, Yu-Sheng Chen, Fengtao You, Dan Chen, Tingting Zhang, Bozhen Zhang, Lin Yang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3830.
https://doi.org/10.1182/blood-2021-147632
Published: 2021
Journal Articles

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Xiaorui Fu, Huimin Meng, Min Wang, Yu Wang, Lei Zhang, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Xiaolong Wu, Guifang Pan, Yanmei Zhao, Yu-Sheng Chen, Fengtao You, Lin Yang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3829.
https://doi.org/10.1182/blood-2021-149999
Published: 2021
Journal Articles

Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study

Yuankai Shi, QingYuan Zhang, Xiaonan Hong, Zhen Wang, Yuhuan Gao, Liqun Zou, Hong Cen, Lin Gui, Yufu Li, Jifeng Feng, Zhao Wang, Mingzhi Zhang, Chuan Jin, Weihua Zhang, Jianda Hu, Chengyun Zheng, Zhendong Zheng, Liling Zhang, Shaoshui Chen, Yunhong Huang, Yun Tang, Yajie Gao, Miaowang Hao, Xiaoling Li, Chunkang Chang, Haiyan Yang, Hui Wu, Lida Shen, Xiaoyan Ke, Liangming Zhang, Yaming Xi, Linhua Yang, Liangzhi Xie
Journal: Blood
Blood (2021) 138 (Supplement 1): 2480.
https://doi.org/10.1182/blood-2021-149861
Published: 2021
Journal Articles

The Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma

Wenting Song, Zhan Chen, Cunzhen Shi, Yuyang Gao, Xiaoyan Feng, Hongwen Li, Zhaoming Li, Mingzhi Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3987.
https://doi.org/10.1182/blood-2021-151786
Published: 2021